This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ALXN CLWR MS NWE TIF

NEW YORK ( TheStreet) --

Acme United (ACU) was downgraded to hold at TheStreet Ratings.

Alexion (ALXN - Get Report) was initiated with a neutral rating at Credit Suisse. $110 price target. Company lacks near-term catalysts, Credit Suisse said.

Biomarin (BMRN) was initiated with a neutral rating at Credit Suisse. Valuation call, based on a $68 price target, Credit Suisse said.

Clearwire (CLWR) was upgraded at DA Davidson to neutral from underperform. $4.40 price target. Expect Sprint Nextel (S) to match DirecTV's (DTV) bid.

Cepheid (CPHD) was downgraded at Jefferies to hold from buy. Valuation call, based on a $38 price target, Jefferies said.

Calpine (CPN) was upgraded at Deutsche Bank to buy from hold. $23 price target. Rising interest rates make company an attractive choice, relative to traditional utilities, Deutsche Bank said.


Exterran (EXH) was upgraded to buy at TheStreet Ratings.

Haemonetics (HAE) was initiated with a neutral rating at Goldman Sachs. Valuation call, based on a $47 price target, Goldman said.

Mellanox (MLNX) was downgraded at UBS to neutral. TASE delisting and the potential split of the CEO and chairman roles will drive near-term pressure, UBS said. Price target is now $57.

Morgan Stanley (MS - Get Report) was upgraded at Deutsche Bank to buy from hold. $30 price target. Stock continues to trade at a discount to tangible book value, even though earnings momentum appears poised to accelerate, Deutsche said.

Myriad (MYGN) was downgraded at Jefferies to hold from buy. $31 price target. Stock is up more than 20%, ahead of the pending Supreme Court decision, Jefferies said.


Northwestern (NWE - Get Report) was upgraded at Robert Baird to outperform from neutral. $47 price target. Natural gas acquisition should boost earnings growth, Baird said.

RF Micro (RFMD) was upgraded at DA Davidson to buy from neutral. Estimates were also increased as the company can expand its gross margin, DA Davidson said.

Scotts Miracle-Gro (SMG) was downgraded at BMO Capital to underperform from market perform. Valuation call, based on a $43 price target, BMO Capital said.

Tiffany (TIF - Get Report) was initiated with an outperform rating at Credit Suisse. $89 price target. Company can deliver low-teens annual earnings growth over the next five years, Credit Suisse said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CLWR $0.00 0.00%
ALXN $180.08 0.00%
MS $37.36 0.00%
NWE $53.12 0.00%
TIF $87.12 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs